Scintigraphic imaging of neuroblastoma with meta-iodobenzylguanidine

1984 ◽  
Vol 104 (4_Supplb) ◽  
pp. S127
Author(s):  
B. KIMMIG ◽  
W. E. BRANDEIS ◽  
M. EISENHUT
Keyword(s):  
Scintigraphic Imaging

Scintigraphic Detection of Experimental Myocardial Infarction with 99mTc-2,3-Dimercaptosuccinic Acid

1984 ◽  
Vol 23 (06) ◽  
pp. 317-319
Author(s):  
J. Novák ◽  
Y. Mazurová ◽  
J. Kubíček ◽  
J. Yižd’a ◽  
P. Kafka ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Coronary Artery ◽  
Intravenous Administration ◽  
Experimental Myocardial Infarction ◽  
Myocardial Infarctions ◽  
Clinical Use ◽  
Scintigraphic Imaging ◽  
Tissue Samples ◽  
Scintigraphic Finding

SummaryAcute myocardial infarctions were produced by ligature of the left frontal descending coronary artery in 9 dogs. The possibility of scintigraphic imaging with 99mTc-DMSA 4 hrs after intravenous administration was studied. The infarctions were 4, 24 and 48 hrs old. The in vivo scan was positive in only one dog with a 4-hr old infarction. The in vivo scans were confirmed by the analysis of the radioactivity in tissue samples. The accumulation of the radiopharmaceutical increased slightly in 48-hr old lesions; however, this increase was not sufficient for a positive scintigraphic finding. Thus, we do not recommend 99mTc-DMSA for clinical use in acute lesions.

Is there a role for scintigraphic imaging of bone manifestations in Gaucher disease?

2008 ◽  
Vol 47 (06) ◽  
pp. 239-247 ◽  
Author(s):  
S. Kohlfürst ◽  
H. J. Gallowitsch ◽  
E. Kresnik ◽  
P. Lind ◽  
A. B. Mehta ◽  
...  
Keyword(s):  
Bone Marrow ◽  
Lysosomal Storage Disease ◽  
Gaucher Disease ◽  
Storage Disease ◽  
Lysosomal Storage ◽  
Scintigraphic Imaging ◽  
Imaging Methods ◽  
X Ray ◽  
Deficient Activity

SummaryGaucher disease is the most prevalent inherited, lysosomal storage disease and is caused by deficient activity of the enzyme β-glucocerebrosidase. Bone and bone marrow alterations are frequent in the most prevalent non-neuronopathic form of Gaucher disease. Imaging of bone manifestations in Gaucher disease is performed by a variety of imaging methods, conventional X-ray and MRI as the most frequently and most important ones. However, different modalities of scintigraphic imaging have also been used. This article gives an overview on scintigraphic imaging with respect to bone manifestations in Gaucher disease discussing the advantages and limitations of scintigraphic imaging in comparison to other imaging methods.

scholarly journals Scintigraphic imaging with technetium-99M-labelled ceftizoxime is a reliable technique for the diagnosis of deep sternal wound infection in rats

2015 ◽  
Vol 30 (9) ◽  
pp. 632-638 ◽  
Author(s):  
Paulo Henrique Nogueira Costa ◽  
Simone Odilia Fernandes Diniz ◽  
Valbert Nascimento Cardoso ◽  
Bernardo Tarabal ◽  
Isabella Takenaka ◽  
...  
Keyword(s):  
Wound Infection ◽  
Deep Sternal Wound Infection ◽  
Sternal Wound Infection ◽  
Scintigraphic Imaging ◽  
Reliable Technique ◽  
Technetium 99M

Radiolabeling of Liposomes for Scintigraphic Imaging

2006 ◽  
pp. 169-185 ◽  
Author(s):  
Peter Laverman ◽  
Gert Storm ◽  
William Phillips ◽  
Ande Bao ◽  
Beth Goins
Keyword(s):  
Scintigraphic Imaging

scholarly journals Biodistribution Study of Niosomes in Tumor-Implanted BALB/C Mice Using Scintigraphic Imaging

2022 ◽  
Vol 12 ◽  
Author(s):  
Leanne De Silva ◽  
Ju-Yen Fu ◽  
Thet Thet Htar ◽  
Wan Hamirul Bahrin Wan Kamal ◽  
Azahari Kasbollah ◽  
...  
Keyword(s):  
Intravenous Injection ◽  
Gamma Scintigraphy ◽  
Biodistribution Study ◽  
Scintigraphic Imaging ◽  
Tumor Bearing ◽  
Tumor Accumulation ◽  
Tumor Area

The purpose of this work was to study the biodistribution of niosomes in tumor-implanted BALB/c mice using gamma scintigraphy. Niosomes were first formulated and characterized, then radiolabeled with Technetium-99 m (99mTc). The biodistribution of 99mTc-labeled niosomes was evaluated in tumor-bearing mice through intravenous injection and imaged with gamma scintigraphy. The labeled complexes possessed high radiolabeling efficiency (98.08%) and were stable in vitro (>80% after 8 h). Scintigraphic imaging showed negligible accumulation in the stomach and thyroid, indicating minimal leaching of the radiolabel in vivo. Radioactivity was found mainly in the liver, spleen and kidneys. Tumor-to-muscle ratio indicated a higher specificity of the formulation for the tumor area. Overall, the formulated niosomes are stable both in vitro and in vivo, and show preferential tumor accumulation.

Scintigraphic imaging of lung tumours with a radiolabelled somatostatin analogue

1993 ◽  
Vol 14 (3) ◽  
pp. 234 ◽  
Author(s):  
K. O??Byrne ◽  
D. Lyons ◽  
M. Istarabadi ◽  
C. O??Donnell ◽  
N. O??Hare ◽  
...  
Keyword(s):  
Somatostatin Analogue ◽  
Scintigraphic Imaging ◽  
Lung Tumours
Sign in / Sign up

Export Citation Format

Share Document